A case of venlafaxine-induced angioedema in an older adult.
Hailee GriffinScott PearsonSunny LinneburDanielle R FixenPublished in: SAGE open medical case reports (2021)
Angioedema is a serious adverse event that can manifest as lower extremity edema, face swelling, rash, hives, and a swollen tongue, which can sometimes lead to airway constriction and death. It is a well-documented reaction within the angiotensin-converting enzyme inhibitor drug class, where the bradykinin pathway leads to angioedema. We report a case where a patient experienced angioedema after taking venlafaxine. We evaluated other antidepressants as potential treatment options for the patient. We further examined potential cross-reactivity between antidepressants in order to find alternative medications for patients that experience serious adverse effects.
Keyphrases
- angiotensin converting enzyme
- angiotensin ii
- end stage renal disease
- major depressive disorder
- case report
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- physical activity
- emergency department
- human health
- high glucose
- diabetic rats
- neuropathic pain
- patient reported outcomes
- oxidative stress
- spinal cord
- adverse drug
- childhood cancer